non-human primateshereditary transthyretin amyloidosisgenetic liver diseasesrare diseasessmall interfering RNA treatmentsLipid nanoparticle-mRNA therapeuticsRNA-based therapeuticsGalNAc conjugation
…ort observation periods. Further preclinical studies, including non-human primates, will be essential for refining trial designs. Despite their po…